Announcements Trials

Browse Landscape

Phase

Status

Recruiting 9 Unknown 8 Active not recruiting 4 Terminated 3 Not yet recruiting 3 Completed 3 Suspended 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pneumonia 1 Lung Neoplasms 1 Lung Diseases, Interstitial 1

Interventions

Specimen Handling 31 Magnetic Resonance Spectroscopy 19 Biopsy 16 Cyclophosphamide 15 Nivolumab 10 Paclitaxel 9 Vincristine 8 Cisplatin 8 venetoclax 7 Prednisone 7 Gemcitabine 7 Doxorubicin 7 Bevacizumab 7 Azacitidine 7 pembrolizumab 6 Radiotherapy 6 Fluorouracil 6 Etoposide 6 Drug Therapy 6 Docetaxel 6 Surgical Procedures, Operative 5 Rituximab 5 Radiosurgery 5 Oxaliplatin 5 Irinotecan 5 Injections 5 Everolimus 5 Capecitabine 5 fludarabine phosphate 4 Taxes 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × Clinical Protocols × Clear all

NCT04036721 2023-02-23

PROS-CONS

National Institute for Tuberculosis and Lung Diseases, Poland

Phase 4 Suspended

Lung Neoplasms, Pneumonia, Lung Diseases, Interstitial

Data powered by HemOnc (CC BY 4.0) Colophon ⚡